{
    "nctId": "NCT03417622",
    "briefTitle": "Wide Margin vs. Narrow Margin in Postneoadjuvant Lumpectomy",
    "officialTitle": "Surgical Resection Margin According to the Post-treatment Tumor Volume Versus the Pre-treatment Tumor Volume in Breast Conservative Surgery for Invasive Breast Cancer Patients Receiving Primary Systemic Therapy: Randomized Controlled Trial",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE3",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 370,
    "primaryOutcomeMeasure": "Local recurrence rate.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Biopsy-proven diagnosis of invasive adenocarcinoma of the breast.\n* Tumor stage T 1-4b\n* Nodal stage N 0-2\n* ASA (American Society of Anesthesiologists) class I-II\n\nExclusion Criteria:\n\n* Patients opting for mastectomy.\n* Patients advised for mastectomy by the treating physician.\n* Patients opting for primary surgical treatment.\n* Patients advised for primary surgical treatment by the treating physician.\n* Metastatic patients.\n* Multifocal tumors.\n* Lobular neoplasia.\n* Current pregnancy or pregnancy less than 6 months from the enrollment date.\n* Active second cancer.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}